|
|
Tradename |
|
|
Trade names are indicative and excipients composition can be different depending on the country and manufacturers
|
|
Amidate |
United States of America |
|
Endatal |
Chile, Mexico |
|
Etomidat |
Germany, Hungary, Luxembourg, Romania, Switzerland |
|
Etomidate |
Belgium, Colombia, Great Britain, Malaysia, New Zealand, Poland, United States of America |
|
Etomidato |
Brazil, Chile, Ecuador, Portugal, Spain |
|
Hypnomidate |
Austria, Belgium, Brazil, France, Germany, Great Britain, Greece, Iran, Luxembourg, Netherlands, Poland, Spain, Tunisia |
|
Hypnomidato |
Portugal |
|
Midatus |
Argentina, Chile |
|
Precedex |
Australia, Brazil, Canada, Chile, Colombia, Ecuador, Japan, Malaysia, Mexico, New Zealand, Peru, Saudi Arabia, United Arab Emirates, United States of America, Venezuela |
|
|
|
|
References : Etomidate |
|
|
Type |
Publication |
| 319 |
Journal |
Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999. |
| 2105 |
Journal |
Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C. Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Farm Hosp 1999 ; 23: 357-360. |
| 3372 |
Journal |
Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166. |
| 5011 |
Manufacturer |
Hypnomidate 2 mg/ml Injection - Summary of Product Characteristics Updated 02-Apr-2024. Piramal Critical Care Limited 2024 |
| 5042 |
Manufacturer |
Dexdor 100 micrograms/ml concentrate for solution for infusion - Summary of Product Characteristics. Orion Corporation 2016 |
| 5096 |
Journal |
Zhang L, Kong L, Deng Q, Chao Y, Fu C, Meng Y. Compatibility and Stability of Cipepofol (Ciprofol) and Etomidate Mixture for Intravenous Anesthesia. Current Ther Res 2025 ; 103: 100810. |
|
|